DR Abernethy

629 total citations
13 papers, 468 citations indexed

About

DR Abernethy is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Psychiatry and Mental health. According to data from OpenAlex, DR Abernethy has authored 13 papers receiving a total of 468 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pediatrics, Perinatology and Child Health, 3 papers in Pharmacology and 3 papers in Psychiatry and Mental health. Recurrent topics in DR Abernethy's work include Pharmacological Effects and Toxicity Studies (4 papers), Epilepsy research and treatment (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). DR Abernethy is often cited by papers focused on Pharmacological Effects and Toxicity Studies (4 papers), Epilepsy research and treatment (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). DR Abernethy collaborates with scholars based in United States, Australia and Austria. DR Abernethy's co-authors include D J Greenblatt, Richard I. Shader, J. B. Schwartz, Marcia Divoll, Victor Crentsil, E. M. Simonsick, L. P. Fried, B. Gwen Windham, DE Mager and Sarah N. Hilmer and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, British Journal of Clinical Pharmacology and Journal of Clinical Psychopharmacology.

In The Last Decade

DR Abernethy

13 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
DR Abernethy United States	9	130	122	99	88	85	13	468
Christopher P Alderman Australia	16	163 1.3×	59 0.5×	107 1.1×	77 0.9×	52 0.6×	65	720
M. D. Rawlins United Kingdom	18	110 0.8×	172 1.4×	128 1.3×	229 2.6×	30 0.4×	45	1.1k
Buster Mannheimer Sweden	19	110 0.8×	145 1.2×	241 2.4×	113 1.3×	47 0.6×	56	845
Pierre Voirol Switzerland	13	54 0.4×	59 0.5×	53 0.5×	52 0.6×	31 0.4×	42	537
Marine L. Andersson Sweden	16	167 1.3×	242 2.0×	66 0.7×	126 1.4×	46 0.5×	32	787
Paul A.F. Jansen Netherlands	17	171 1.3×	53 0.4×	135 1.4×	87 1.0×	16 0.2×	25	589
Rabia S. Atayee United States	18	188 1.4×	110 0.9×	85 0.9×	254 2.9×	58 0.7×	76	1.1k
Eline M. Rodenburg Netherlands	13	86 0.7×	29 0.2×	54 0.5×	69 0.8×	42 0.5×	15	687
Malavika Deodhar United States	12	50 0.4×	97 0.8×	77 0.8×	47 0.5×	63 0.7×	15	495
Siegfried Schmidt United States	15	45 0.3×	136 1.1×	97 1.0×	115 1.3×	41 0.5×	43	910

Countries citing papers authored by DR Abernethy

Since Specialization

Citations

This map shows the geographic impact of DR Abernethy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DR Abernethy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DR Abernethy more than expected).

Fields of papers citing papers by DR Abernethy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DR Abernethy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DR Abernethy. The network helps show where DR Abernethy may publish in the future.

Co-authorship network of co-authors of DR Abernethy

This figure shows the co-authorship network connecting the top 25 collaborators of DR Abernethy. A scholar is included among the top collaborators of DR Abernethy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DR Abernethy. DR Abernethy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Yoshida, Kenta, Bo Sun, L Zhang, et al.. (2016). Systematic and quantitative assessment of the effect of chronic kidney disease on CYP2D6 and CYP3A4/5. Clinical Pharmacology & Therapeutics. 100(1). 75–87. 49 indexed citations

Abernethy, DR, et al.. (2008). Finding the Right Research Question: Quality Science Depends on Quality Careers. Clinical Pharmacology & Therapeutics. 84(3). 427–429. 3 indexed citations

Abernethy, DR, et al.. (2008). Aging and Medications: Past, Present, Future. Clinical Pharmacology & Therapeutics. 85(1). 3–10. 6 indexed citations

Abernethy, DR, et al.. (2008). Adulteration of Drugs and Foods: Compendial Approaches to Lowering Risk. Clinical Pharmacology & Therapeutics. 85(4). 444–447. 7 indexed citations

Mager, DE, E. M. Simonsick, Sarah N. Hilmer, et al.. (2007). Physical and Cognitive Performance and Burden of Anticholinergics, Sedatives, and ACE Inhibitors in Older Women. Clinical Pharmacology & Therapeutics. 83(3). 422–429. 145 indexed citations

Abernethy, DR, et al.. (1987). N‐monodesmethyldiltiazem is the predominant metabolite of diltiazem in the plasma of young and elderly hypertensives.. British Journal of Clinical Pharmacology. 24(2). 185–189. 39 indexed citations

Abernethy, DR, et al.. (1986). Obesity effects on nitrazepam disposition.. British Journal of Clinical Pharmacology. 22(5). 551–557. 16 indexed citations

Schwartz, J. B., et al.. (1985). An investigation of the cause of accumulation of verapamil during regular dosing in patients.. British Journal of Clinical Pharmacology. 19(4). 512–516. 24 indexed citations

Abernethy, DR, D J Greenblatt, Diane S. Morse, & Richard I. Shader. (1985). Interaction of propoxyphene with diazepam, alprazolam and lorazepam.. British Journal of Clinical Pharmacology. 19(1). 51–57. 34 indexed citations

10.

Abernethy, DR, D J Greenblatt, Diane S. Morse, & Richard I. Shader. (1985). Interaction of propoxyphene with diazepam, alprazolam and lorazepam. Journal of Clinical Psychopharmacology. 5(5). 306–306. 1 indexed citations

11.

Abernethy, DR, et al.. (1985). Caffeine disposition in obesity.. British Journal of Clinical Pharmacology. 20(1). 61–66. 39 indexed citations

12.

Greenblatt, D J, et al.. (1983). Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.. British Journal of Clinical Pharmacology. 15(3). 303–309. 73 indexed citations

13.

Greenblatt, D J, et al.. (1981). Diazepam kinetics in patients with renal insufficiency or hyperthyroidism.. British Journal of Clinical Pharmacology. 12(6). 829–832. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact